GCKR
GCKRgeneGCKR variants modulate hepatic glucose and lipid metabolism, reducing atherogenic dyslipidemia and systemic cardiovascular risk.
Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencemedium
RationaleGlucokinase regulator; glucose sensing and hepatic lipid metabolism modulator; protective CAD association via lipid pathways.
Also acts inLipid entry/oxidation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome-Wide Mendelian Randomization and Colocalization Analysis.Cardiovascular therapeutics · 2025 · PMID 40026415 · doi